FDA and Vouchers for Neglected Diseases: A Bad Idea Gone Bad
Read More:
Malaria,
Healthcare Vouchers,
Fda,
Neglected Diseases,
Disease,
Health,
Living,
Living News
The unintended consequences of an ill-conceived incentive scheme will be on full display when Novartis goes before an FDA advisory committee seeking approval for its anti-malarial pill.
Merrill Goozner | Posted 12.08.2008 | Living